January 09, 2026

Leopardlike PET Pattern and Sarcoidlike Reaction

A rare but often favorable immune-related adverse event associated with immune checkpoint inhibitors can mimic cancer progression on imaging and typically resolves with conservative management.

Conexiant

December 17, 2025

Lung Cancer Screening Follow-up Shows Gaps

Investigators highlight disparities in diagnostic follow-up intensity after abnormal lung cancer screening findings across Lung Imaging Reporting and Data System categories using a national analysis of registry-linked Medicare data.

Conexiant

December 16, 2025

Top 10 States to Practice Radiology

The following list highlights the states that offer the most favorable conditions for radiologists.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

August 07, 2025

Allogeneic Islet Transplant Shows Promise Without Immunosuppression

First-in-human trial shows genetically engineered islet cells restore insulin secretion in type 1 diabetes without triggering immune rejection.

Conexiant

September 26, 2025

Age 80 and Beyond: The Screening Debate

How mammography after age 80 affects breast cancer stage at diagnosis and survival.

Conexiant

October 27, 2025

Why Open Access May Not Boost Citations

Researchers found that companion open access journals charge high publication fees yet yield fewer citations than traditional journals.

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant